Digital Transformation in Pharma: DRAP Clearance Gateway Goes Live

PSW and the Drug Regulatory Authority of Pakistan (DRAP) officially launched the DRAP Clearance Gateway, marking a significant step towards digitalizing regulatory processes in the pharmaceutical sector. The launch event brought together key stakeholders, including representatives from government organizations, international development partners, and the pharmaceutical industry, to discuss the platform’s impact on trade efficiency and regulatory compliance.

The DRAP Clearance Gateway is designed to enhance transparency, reduce administrative delays, and expedite the clearance of pharmaceutical products. By replacing outdated manual processes with a digital framework, the system simplifies regulatory requirements, eliminating redundancies and improving overall efficiency in the pharmaceutical supply chain. The platform ensures real-time tracking of approvals and significantly reduces processing times, benefiting both importers and exporters of pharmaceutical products.

During the launch, a panel discussion on Driving Digital Transformation in the Pharmaceutical Industry and the WHO Digital Health Strategy brought together key industry stakeholders. The discussion focused on how digital trade solutions, including the DRAP Clearance Gateway, facilitate seamless approvals, enhance compliance, and expand global market access for Pakistan’s pharmaceutical sector. The platform is also expected to accelerate the import of life-saving vaccines and medicines, ensuring faster delivery to organizations such as UNICEF and improving healthcare outcomes for vulnerable populations.

The introduction of the DRAP Clearance Gateway aligns with the Government of Pakistan’s vision to modernize trade and regulatory frameworks. By streamlining processes and reducing operational costs, PSW continues to drive digital transformation, reinforcing Pakistan’s position as a competitive player in the global pharmaceutical market.

.

.